RxDoctor Payments Data
★ My doctorsLook up a doctor →

Russell Nevins, MD

Orthopaedic Surgery · Las Vegas, NVNPI 1306845649

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,040,729 of the $1,528,164 with a category attached, or 68.1%. 18 manufacturers reported payments, led by Microport Orthopedics Inc at 36.3% of the total. Among orthopaedic surgery clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,528,164in general payments, 2019–2025

Across 299 payments — averaging $5110.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microport Orthopedics Inc$554K
  • Depuy Synthes Products, Inc.$544K
  • Linkbio Corp$424K
  • Stryker$2K
  • Johnson & Johnson$1K
  • Pacira Therapeutics, Inc.$1K
  • plus $1K from 12 others
$24,637in research payments, 2019–2025

Across 2 payments — averaging $12,318 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Microport Orthopedics Inc$25K

What the payments were for

  • Royalty or licence$1,040,72968%
  • Consulting fees$386,25425%
  • Speaking & faculty fees$18,9001%
  • Travel & lodging$72,3795%
  • Food & beverage$9,9031%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Microport Orthopedics Inc73$554,477
Depuy Synthes Products, Inc.33$544,157
Linkbio Corp53$423,654
Stryker8$2,170
Johnson & Johnson40$1,232
Pacira Therapeutics, Inc.70$1,119
Medical Device Business Services, Inc.2$604
Organogenesis Inc.2$170
Next Science LLC1$136
Medacta USA, Inc.1$103
Ferring Pharmaceuticals Inc.6$89
Pacira Pharmaceuticals Incorporated2$72
Sanara Medtech Inc.2$63
Argentum Medical1$37
UOC USA Inc1$24
Goode Surgical Inc1$23
Avanos Medical1$20
Maxx Orthopedics, Inc.2$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,528,164 in reported general payments places this provider in the 95th percentile of 135 orthopaedic surgery providers in Nevada.

See all orthopaedic surgery providers in Nevada →

Medicare billing

Part B allowed, 2024
$564,143
Medicare patients
815
Services billed
33,431

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam93$193
Cephalexin67$155
Cyclobenzaprine Hcl31$98
Gabapentin23$98
Methylprednisolone20$89
Oxycodone Hcl15$80

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Las Vegas

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →